Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular, Sanofi Ink Companion Dx Deal

NEW YORK (GenomeWeb News) – HTG Molecular Diagnostics today said that it will collaborate with Sanofi US on identifying biomarkers that could become a molecular companion diagnostic test.

The potential test would identify patients most likely to respond to an investigational drug being developed by Sanofi.

HTG Molecular, a privately-held, Tucson, Ariz.-based firm, will use its qNPA technology to measure mRNA and/or miRNA expression in formalin fixed paraffin embedded tumor samples. The technology, according to the firm, enables physicians to verify the presence of certain biomarkers relevant to patient selection and therapy.

Financial and other terms of the alliance were not disclosed.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.